Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20354)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Mean Normalized Growth Rate Inhibition Value | Increased Fraction Dead |
|---|---|---|---|---|
| HME1 | GSK2334470 | 0.003162278 | 0.9777 | 0.00129 |
| HME1 | GSK2334470 | 0.01 | 0.9492 | -0.00097 |
| HME1 | GSK2334470 | 0.01 | 0.8113 | 0.00555 |
| HME1 | GSK2334470 | 0.01 | 0.8658 | 0.01756 |
| HME1 | GSK2334470 | 0.031622777 | 0.9076 | -0.00235 |
| HME1 | GSK2334470 | 0.031622777 | 0.8733 | 0.00734 |
| HME1 | GSK2334470 | 0.031622777 | 0.8427 | 0.03119 |
| HME1 | GSK2334470 | 0.1 | 0.9938 | -0.00643 |
| HME1 | GSK2334470 | 0.1 | 0.9610 | 0.00113 |
| HME1 | GSK2334470 | 0.1 | 0.9097 | 0.01894 |
| HME1 | GSK2334470 | 0.316227766 | 0.7099 | 0.05134 |
| HME1 | GSK2334470 | 0.316227766 | 0.8145 | 0.00254 |
| HME1 | GSK2334470 | 0.316227766 | 0.8731 | 0.01113 |
| HME1 | GSK2334470 | 1.0 | 0.9158 | -0.00281 |
| HME1 | GSK2334470 | 1.0 | 0.8013 | 0.01080 |
| HME1 | GSK2334470 | 1.0 | 0.7722 | 0.04333 |
| HME1 | GSK2334470 | 3.16227766 | 0.8316 | 0.01971 |
| HME1 | GSK2334470 | 3.16227766 | 0.8780 | -0.00732 |
| HME1 | GSK2334470 | 3.16227766 | 0.7901 | 0.03544 |
| HME1 | GSK2334470 | 10.0 | 0.5435 | 0.09233 |
| HME1 | GSK2334470 | 10.0 | 0.6784 | 0.04826 |
| HME1 | GSK2334470 | 10.0 | 0.6993 | 0.04050 |
| HME1 | Ribociclib | 0.001 | 0.8052 | 0.00106 |
| HME1 | Ribociclib | 0.001 | 0.9068 | -0.00175 |
| HME1 | Ribociclib | 0.001 | 0.8596 | 0.00877 |